Search results
Mainz Biomed Announces Submission for FDA Breakthrough Device Designation for its Next Generation CR
PharmiWeb· 2 days agoIssuer: Mainz BioMed N.V. / Key word(s): Regulatory Admission09.07.2024 / 09:01 CET/CESTThe issuer is solely responsible for the content of this announcement.Mainz Biomed Announces Submission ...